drugset
drugset / Trial / NCT00734565

Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b

NCT00734565 ↗

Phase 1 Completed 40 enrolled Novartis Vaccines
Non-randomizedSingle-groupOpen-labelPrevention

Summary

This study will investigate safety and reactogenicity of a monovalent conjugated vaccine against Haemophilus influenzae type b in healthy children

Timeline

Start
2008-07
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Haemophilus influenzae type b Vaccine 1 unknown —

Indications

haemophilus infectious disease